We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAYN
1301
DELISTED
Layne Christensen Co
LAYN
$54K ﹤0.01%
6,068
+5,277
+667% +$40K
LUX
1302
DELISTED
Luxottica Group
LUX
$54K ﹤0.01%
+820
New +$54.3K
TPLM
1303
DELISTED
Triangle Petroleum Corporation
TPLM
$54K ﹤0.01%
10,834
+9,383
+647% +$50.4K
WPG
1304
DELISTED
Washington Prime Group Inc.
WPG
$54K ﹤0.01%
441
+30
+7% +$3.96K
ABR icon
1305
Arbor Realty Trust
ABR
$974M
$53K ﹤0.01%
7,928
+2,399
+43% +$16.6K
DAKT icon
1306
Daktronics
DAKT
$1.04B
$53K ﹤0.01%
4,474
+2,348
+110% +$26K
EDEN icon
1307
iShares MSCI Denmark ETF
EDEN
$201M
$53K ﹤0.01%
978
+86
+10% +$4.76K
ITIC
1308
Investors Title Co
ITIC
$547M
$53K ﹤0.01%
741
+389
+111% +$28.2K
NVDA icon
1309
NVIDIA
NVDA
$5.13T
$53K ﹤0.01%
104,720
+101,080
+2,777% +$54.8K
PTEN icon
1310
Patterson-UTI
PTEN
$3.83B
$53K ﹤0.01%
2,808
+570
+25% +$11.8K
PXLW icon
1311
Pixelworks
PXLW
$39.7M
$53K ﹤0.01%
758
+476
+169% +$29.9K
SANM icon
1312
Sanmina
SANM
$11.1B
$53K ﹤0.01%
2,630
-5,203
-66% -$114K
NPTN
1313
DELISTED
NEOPHOTONICS CORP
NPTN
$53K ﹤0.01%
+5,777
New +$43.8K
GMZ
1314
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$53K ﹤0.01%
503
+474
+1,634% +$57.2K
KND
1315
DELISTED
Kindred Healthcare
KND
$53K ﹤0.01%
+2,594
New +$59.4K
TLMR
1316
DELISTED
TALMER BANCORP INC (MI)
TLMR
$53K ﹤0.01%
3,158
+853
+37% +$13.8K
AGO icon
1317
Assured Guaranty
AGO
$3.67B
$52K ﹤0.01%
2,188
+2,157
+6,958% +$60.1K
AMPH icon
1318
Amphastar Pharmaceuticals
AMPH
$877M
$52K ﹤0.01%
+2,960
New +$46.1K
ANGO icon
1319
AngioDynamics
ANGO
$628M
$52K ﹤0.01%
3,166
+2,085
+193% +$34.6K
AWP
1320
abrdn Global Premier Properties Fund
AWP
$369M
$52K ﹤0.01%
2,667
+1,067
+67% +$22K
BBDC icon
1321
Barings BDC
BBDC
$897M
$52K ﹤0.01%
2,210
+2,140
+3,057% +$50.7K
BSX icon
1322
Boston Scientific
BSX
$71.1B
$52K ﹤0.01%
+2,934
New +$52.4K
DEO icon
1323
Diageo
DEO
$48.8B
$52K ﹤0.01%
449
-437
-49% -$49.7K
FSLR icon
1324
First Solar
FSLR
$26.2B
$52K ﹤0.01%
+1,113
New +$62.2K
HEES
1325
DELISTED
H&E Equipment Services
HEES
$52K ﹤0.01%
2,603
+1,358
+109% +$32.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.